SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,528,081 | -38.0% | 15,898,729 | -4.5% | 0.01% | -37.5% |
| Q2 2023 | $99,198,628 | +65.7% | 16,644,065 | -9.1% | 0.01% | +166.7% |
| Q1 2023 | $59,867,768 | +65.3% | 18,308,186 | +99.7% | 0.00% | -25.0% |
| Q4 2022 | $36,219,169 | -34.4% | 9,169,410 | -0.4% | 0.00% | -33.3% |
| Q3 2022 | $55,240,000 | -11.9% | 9,206,685 | -5.6% | 0.01% | 0.0% |
| Q2 2022 | $62,684,000 | -17.8% | 9,748,674 | +5.6% | 0.01% | 0.0% |
| Q1 2022 | $76,290,000 | -42.9% | 9,236,067 | +7.0% | 0.01% | -40.0% |
| Q4 2021 | $133,559,000 | -29.8% | 8,627,851 | +2.1% | 0.01% | -33.3% |
| Q3 2021 | $190,356,000 | +13.3% | 8,452,744 | -1.1% | 0.02% | +15.4% |
| Q2 2021 | $168,076,000 | -42.5% | 8,549,177 | -2.1% | 0.01% | -48.0% |
| Q1 2021 | $292,373,000 | – | 8,735,390 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |